Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes

Abstract

OBJECTIVEThe prognostic significance of diabetic retinopathy (DR) for death and cardiovascular (CV) outcomes is debated. We investigated the association of DR with all-cause mortality and CV events in patients with diabetes by a systematic review and meta-analysis.RESEARCH DESIGN AND METHODSThe electronic databases Medline and Embase were searched for cohort studies that evaluated DR in type 2 or type 1 diabetic patients and reported total mortality and/or fatal and nonfatal CV events, including myocardial infarction, angina pectoris, coronary artery bypass graft, ischemic changes on a conventional 12-lead electrocardiogram, transient ischemic attack, nonfatal stroke, or lower leg amputation. Data extraction was performed by two reviewers independently. Pooled effect estimates were obtained by using random-effects meta-analysis.RESULTSThe analysis included 20 studies that fulfilled the inclusion criteria, providing data from 19,234 patients. In patients with type 2 diabetes (n = 14,896), the presence of any degree of DR increased the chance for all-cause mortality and/or CV events by 2.34 (95% CI 1.96–2.80) compared with patients without DR. In patients with type 1 diabetes (n = 4,438), the corresponding odds ratio was 4.10 (1.50–11.18). These associations remained after adjusting for traditional CV risk factors. DR was also predictive of all-cause mortality in type 2 diabetes (odds ratio 2.41 [1.87–3.10]) and type 1 diabetes (3.65 [1.05–12.66]).CONCLUSIONSThe presence of DR was associated with an increased risk of all-cause mortality and CV events in both type 2 and type 1 diabetic patients.

Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond

“…However, it should not be forgotten that diabetic retinopathy is part of a systemic disease and predicts cardiovascular morbidity and mortality [73]. The genetics of diabetic retinopathy are clearly distinct from those of diabetic nephropathy and the search for a biomarker for improving the prediction of this malignant clinical course has failed so far, leaving microaneurysms as the best predictor ('biomarker') of the clinical course ('One microaneurysm is not an innocent finding', as E. M. Kohner [Dept.…”

Association of Diabetic Retinopathy and Maculopathy with Elevated HbA1c, Blood Pressure, Serum Creatinine, Microalbuminuria, Spot Urine Protein, Nephropathy and Diabetic Kidney Disease. An Experience from Data Analysis of 10,580 Diabetic Patients

“…Co-existence of retinopathy with nephropathy usually indicates that nephropathy is due to diabetes and termed as diabetic kidney disease (DKD) or diabetic proteinuria. However, especially in type-1 diabetics, the presence of proteinuria in association with short diabetes duration and/ or rapid decline of renal function, especially in the absence of diabetic retinopathy, warrants the need for renal biopsy [46][47][48][49][50][51][52][53][54][55].…”

Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial

“…Diabetic retinopathy is a common chronic microvascular complication of DM 8) . In patients with type 2 DM and retinopathy, the risk of incident coronary heart disease and ischemic stroke is elevated independently of known risk factors 9,10) .…”

“…In patients with type 2 DM and retinopathy, the risk of incident coronary heart disease and ischemic stroke is elevated independently of known risk factors 9,10) . Diabetic retinopathy is strongly associated with all-cause mortality 8) . Therefore, this form of microvascular disease may contribute to the development of CVD.…”